Evaluation of reperfusion and recovery of brain function before and after intracarotid arterial urokinase therapy in acute cerebral infarction with brain SPECT

Clinical Nuclear Medicine

Volumn 24, Issue 8, 1999, Pages 566-571

  Ryu, Young Hoon ^a   Chung, Tae Sub ^a,c   Yoon, Pyeoung Ho ^a   Kim, Dong Ik ^a   Lee, Jong Doo ^a   Lee, Byung In ^a   Suh, Jung Ho ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Brain; Reperfusion; SPECT; Stroke urokinase

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; UROKINASE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN PERFUSION; CAROTID ARTERIOGRAPHY; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFECT; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; PROGNOSIS; RECANALIZATION; REPERFUSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACUTE DISEASE; ADULT; AGED; BRAIN; CAROTID ARTERIES; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; TECHNETIUM TC 99M EXAMETAZIME; THROMBOLYTIC THERAPY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0345104427     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199908000-00004     Document Type: Article

References (20)

1. del Zoppo GJ, Poeck K, Pessin MS, et al: Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32:78, 1992.
2. Mori E, Yoneda Y, Tabuchi M, et al: Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 42:976, 1992.
3. Hacke W, Zeumer H, Ferbert A, et al: Intra-arterial thrombolytic therapy improves outcome in patients with vertebro-basilar occlusive disease. Stroke 19:1216, 1988.
4. Karnik R, Stelzer P, Slany J: Transcranial doppler sonography monitoring of local intra-arterial thrombolysis in acute occlusion of the middle cerebral artery. Stroke 23:284, 1992.
5. von Kummer R, Hacke W: Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23:646, 1992.
6. Herderschee D, Limburg M, van Royen EA, et al: Thrombolysis with tissue plasminogen activator in acute ischemic stroke: Evaluation with rCBF-SPECT. Acta Neurol Scand 83:317, 1991.
7. Limburg M, van Royen EA, Hijdra A, de Bruine JF, Verbeeten BWJ: Single-photon emission computed tomography and early death in acute ischemic stroke. Stroke 21:1150, 1990.
8. Baird AE, Donnan GA, Austin MC, et al: Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography. Stroke 25:79, 1994.
9. Ringelstein EB, Biniek R, Weiller C, et al: Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 42:289, 1992.
10. Lee BI, Lee BC, Park SC, et al: Intra-carotid arterial thrombolytic therapy in acute ischemic stroke of carotid arterial territory. Yonsei Medical Journal 35:49, 1994.
11. Cote R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C: The Canadian neurological scale: A preliminary study in acute stroke. Stroke 17:731, 1986.
12. Brott TG, Harley EC Jr, Levy DE, et al: Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23:632, 1992.
13. Harley EC Jr, Levy DE, Brott TG, et al. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 23:641, 1992.
14. Ueda T, Hatakeyama T, Kumon Y, et al: Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 25:298, 1994.
15. Mountz JM, Modell JG, Foster NL, et al: Prognostication of recovery following stroke using the comparison of CT and technetium-99m HMPAO SPECT. J Nucl Med 31:61, 1990.
16. Anderson AR, Friberg HH, Schmidt JF, Hasselbach SG: Quantitative measurements of cerebral blood flow using SPECT and Tc-99m-d,1-HMPAO compared to Xenon-133. J Cereb Blood Flow Metab 8:S69, 1988.
17. Sharp PF, Smith FW, Gemmell HG, et al: Technetium-99m HMPAO stereoisomers as potential agents for imaging regional cerebral blood flow: Human volunteer studies. J Nucl Med 27:171, 1986.
18. Mori E: Safety and efficacy of fibrinolytic agents in acute ischemic stroke. Cerebrovasc Dis 3:264, 1993.
19. Morawetz RB, Degirolami U, Ojemann RG, Marcox FW, Cromwell RM: Cerebral blood flow determined by hydrogen clearance during middle cerebral artery occlusion in unanesthetized monkeys. Stroke 9:143, 1978.
20. Tamura A, Asano T, Sano K: Correlation between rCBF and histological changes following temporal middle cerebral artery occlusion. Stroke 11:487, 1980.